Literature DB >> 18268402

The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism.

Yuichi Matsumoto1, Jun Funahashi, Kiyotoshi Mori, Kozue Hayashi, Hiroshi Yano.   

Abstract

Calcium responses to various concentrations of histamine were monitored in Chinese hamster ovary cells stably expressing the human histamine H(1) receptor. The effects of various histamine H(1) receptor antagonists on the dose-response curve for histamine were evaluated. Olopatadine hydrochloride (olopatadine) inhibited the histamine-induced maximum response (pD(2)': 7.5) but had insignificant effects on histamine EC(50) values. This noncompetitive property exhibited by olopatadine, which was also observed in human umbilical vein endothelial cells, was the most striking among the antihistamines tested in this study. The geometrical isomer of olopatadine (E-isomer), which had a similar binding affinity to the histamine H(1) receptor as olopatadine, showed a mixed antagonistic profile (competitive and noncompetitive). These results indicate that the geometry around the double bond in the dimethylaminopropylidene group is critical for the potent noncompetitive property of olopatadine. Furthermore, binding mode analyses suggest that the protonated amine group in the dimethylaminopropylidene moiety of olopatadine forms an ionic bond with Glu 181 that is present in the second extracellular loop of the histamine H(1) receptor, whereas the amine group of the E-isomer does not. The second extracellular loop in aminergic G-protein-coupled receptors contributes to ligand binding and therefore the noncompetitive property of olopatadine may be explained by the interaction with Glu 181. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268402     DOI: 10.1159/000115970

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  Structure of the human histamine H1 receptor complex with doxepin.

Authors:  Tatsuro Shimamura; Mitsunori Shiroishi; Simone Weyand; Hirokazu Tsujimoto; Graeme Winter; Vsevolod Katritch; Ruben Abagyan; Vadim Cherezov; Wei Liu; Gye Won Han; Takuya Kobayashi; Raymond C Stevens; So Iwata
Journal:  Nature       Date:  2011-06-22       Impact factor: 49.962

2.  Effects of olopatadine hydrochloride, a histamine h(1) receptor antagonist, on histamine-induced skin responses.

Authors:  Takashi Hashimoto; Norito Ishii; Takahiro Hamada; Teruki Dainichi; Tadashi Karashima; Takekuni Nakama; Shinichiro Yasumoto
Journal:  Dermatol Res Pract       Date:  2010-09-16

3.  Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.

Authors:  Hiroyuki Kamei; Ami Isaji; Yukihiro Noda; Kazuhiro Ishikawa; Koji Senzaki; Kiyofumi Yamada; Kazumitsu Sugiura; Yasushi Tomita; Toshitaka Nabeshima
Journal:  Arch Dermatol Res       Date:  2011-12-01       Impact factor: 3.017

4.  Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial.

Authors:  Atsuki Fukushima; Nobuyuki Ebihara
Journal:  Adv Ther       Date:  2014-10-01       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.